Business Description
Walgreens Boots Alliance Inc
NAICS : 446110
SIC : 5912
108 Wilmot Road, Deerfield, IL, USA, 60015
Compare
Compare
Traded in other countries / regions
WBA.Austria
•
WGBA34.Brazil
•
W8A.Germany
•
WBA.Mexico
•
WBA.Switzerland
•
0LSZ.UK
•
WBA.USA
Description
Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%).
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 1.42 | |||||
Debt-to-EBITDA | 4.63 | |||||
Interest Coverage | 7.23 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.51 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5 | |||||
3-Year EBITDA Growth Rate | -12.5 | |||||
3-Year EPS without NRI Growth Rate | -23.1 | |||||
3-Year FCF Growth Rate | -11.4 | |||||
3-Year Book Growth Rate | -0.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Industry Rank | -2.04 | |||||
Future 3-5Y Total Revenue Growth Rate Industry Rank | 2 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 97.41 | |||||
9-Day RSI | 76.08 | |||||
14-Day RSI | 58.57 | |||||
6-1 Month Momentum % | -23.54 | |||||
12-1 Month Momentum % | -20.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.78 | |||||
Quick Ratio | 0.43 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 30.15 | |||||
Days Sales Outstanding | 14.73 | |||||
Days Payable | 40.16 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.91 | |||||
Dividend Payout Ratio | 0.32 | |||||
3-Year Dividend Growth Rate | 4.7 | |||||
Forward Dividend Yield % | 5.05 | |||||
5-Year Yield-on-Cost % | 6.48 | |||||
3-Year Average Share Buyback Ratio | 3.1 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.82 | |||||
Operating Margin % | 2.03 | |||||
Net Margin % | 4 | |||||
ROE % | 21.56 | |||||
ROA % | 5.91 | |||||
ROIC % | 3 | |||||
ROC (Joel Greenblatt) % | 17.66 | |||||
ROCE % | 9.21 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 6.43 | |||||
Forward PE Ratio | 8.22 | |||||
PE Ratio without NRI | 6.64 | |||||
Shiller PE Ratio | 9.63 | |||||
Price-to-Owner-Earnings | 4.65 | |||||
PS Ratio | 0.25 | |||||
PB Ratio | 1.32 | |||||
Price-to-Free-Cash-Flow | 10.05 | |||||
Price-to-Operating-Cash-Flow | 6.83 | |||||
EV-to-EBIT | 11.16 | |||||
EV-to-Forward-EBIT | 15.65 | |||||
EV-to-EBITDA | 8.36 | |||||
EV-to-Forward-EBITDA | 11.54 | |||||
EV-to-Revenue | 0.5 | |||||
EV-to-Forward-Revenue | 0.5 | |||||
EV-to-FCF | 19.38 | |||||
Price-to-Projected-FCF | 0.47 | |||||
Price-to-Median-PS-Value | 0.43 | |||||
Earnings Yield (Greenblatt) % | 8.96 | |||||
Forward Rate of Return (Yacktman) % | 6.98 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 2,739,704.564 | ||
EPS (TTM) (MXN) | 128.132 | ||
Beta | -0.15 | ||
Volatility % | 21.54 | ||
14-Day RSI | 58.57 | ||
14-Day ATR (MXN) | 2.810753 | ||
20-Day SMA (MXN) | 789.7 | ||
12-1 Month Momentum % | -20.47 | ||
52-Week Range (MXN) | 760.08 - 1120 | ||
Shares Outstanding (Mil) | 864.26 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Walgreens Boots Alliance Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |